Literature DB >> 10373395

Therapeutic potential of selective PDE inhibitors in asthma.

C Schudt1, F Gantner, H Tenors, A Hatzelmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10373395     DOI： 10.1006/pupt.1999.0182

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN： 1094-5539            Impact factor:   3.410


× No keyword cloud information.
  8 in total

Review 1.  Novel drugs for treating asthma.

Authors:  T T Hansel; P J Barnes
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

2.  The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma.

Authors:  Dave Singh; Frank Petavy; Alex J Macdonald; Aili L Lazaar; Brian J O'Connor
Journal:  Respir Res       Date:  2010-03-01

3.  Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.

Authors:  Malcolm C Shepherd; George S Baillie; David I Stirling; Miles D Houslay
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

4.  Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.

Authors:  Gail M Gauvreau; Louis-Philippe Boulet; Christine Schmid-Wirlitsch; Johanne Côté; Mylinh Duong; Kieran J Killian; Joanne Milot; Francine Deschesnes; Tara Strinich; Richard M Watson; Dirk Bredenbröker; Paul M O'Byrne
Journal:  Respir Res       Date:  2011-10-26

5.  The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma.

Authors:  Brian R Leaker; Dave Singh; Ferhana Y Ali; Peter J Barnes; Brian O'Connor
Journal:  BMC Pulm Med       Date:  2014-10-28       Impact factor: 3.317

6.  Spatiotemporal Changes in the Gene Expression Spectrum of the β2 Adrenergic Receptor Signaling Pathway in the Lungs of Rhesus Monkeys.

Authors:  Zhongmei Zheng; Bangrong Cao; Yu Hu; Liang Xie; Ling Gu; Fang Shi; Hanmin Liu
Journal:  Lung       Date:  2021-01-29       Impact factor: 2.584

7.  Liquiritigenin enhances cyclic adenosine monophosphate production to mitigate inflammation in dendritic cells.

Authors:  Mingming Qin; Aili Guo; Feng Li; Fuxiang Zhang; Meirong Bi; Yamin Zhang; Weiwei Zhu
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

8.  High miR203a-3p and miR-375 expression in the airways of smokers with and without COPD.

Authors:  Jos van Nijnatten; Corry-Anke Brandsma; Katrina Steiling; Pieter S Hiemstra; Wim Timens; Maarten van den Berge; Alen Faiz
Journal:  Sci Rep       Date:  2022-04-04       Impact factor: 4.996
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.